TKD Heart Failure Education Programme – Module 2: HFpEF and Cardiomyopathies

    Dates:
    Organizer:
    Turkish Society of Cardiology (Türk Kardiyoloji Derneği)
    Location:
    Turkish Society of Cardiology Centre, İstanbul, Türkiye
    Specialty:
    Cardiology
    Format:
    In-Person

    The Turkish Society of Cardiology (TKD) Heart Failure Education Programme — Module 2 (Kalp Yetersizliği Eğitim Programı, 2. Modül) is a structured four-day course run by the society's Heart Failure Working Group. It takes place from Thursday 10 to Sunday 13 December 2026 at the Turkish Society of Cardiology Centre (Türk Kardiyoloji Derneği Merkezi) in İstanbul, Türkiye, and is taught in Turkish. M

    TKD Heart Failure Education Programme – Module 2: HFpEF and Cardiomyopathies

    TKD Heart Failure Education Programme – Module 2: HFpEF and Cardiomyopathies1 / 1

    1 photo · tap to enlarge

    TKD Heart Failure Education Programme – Module 2: HFpEF and Cardiomyopathies

    Listed 18 Nov 2026

    About this event

    The Turkish Society of Cardiology (TKD) Heart Failure Education Programme — Module 2 (Kalp Yetersizliği Eğitim Programı, 2. Modül) is a structured four-day course run by the society's Heart Failure Working Group. It takes place from Thursday 10 to Sunday 13 December 2026 at the Turkish Society of Cardiology Centre (Türk Kardiyoloji Derneği Merkezi) in İstanbul, Türkiye, and is taught in Turkish. Module 2 is dedicated to heart failure with preserved ejection fraction (HFpEF) and the cardiomyopathies.

    Programme

    The official scientific programme (PDF) is organised into twelve lectures. Day one, opened by Dr Hakkı Kaya, covers the updated definition and classification of heart failure, HFpEF epidemiology, pathophysiology, aetiology and phenotyping, and the diagnostic approach: echocardiography, invasive haemodynamics, cardiopulmonary exercise testing and scoring systems. Day two addresses comorbidities — cardio-renal-metabolic syndrome, atrial fibrillation and pulmonary hypertension — and pharmacological therapy, including SGLT2 inhibitors, steroidal and non-steroidal MRAs, incretin-based therapies, RAS inhibitors and beta-blockers, followed by exercise and caloric restriction, device-based therapies, immunisation and heart failure in cardio-oncology. The final days cover hypertrophic cardiomyopathy, amyloidosis and specific cardiomyopathies, ending with case-based discussion of HFpEF and cardiomyopathies and a closing summary.

    Faculty

    Lecturers and chairs include Hakkı Kaya, İnci Tuğçe Çöllüoğlu, Selda Murat, Ahmet Çelik, Emir Derviş, Nihan Kahya Eren, Rezzan Deniz Acar, Anıl Şahin, Yüksel Çavuşoğlu, Tolga Sinan Güvenç, Sevgi Özcan, Ümit Yaşar Sinan, Hakan Altay, Mehmet Birhan Yılmaz, Taner Şen, Dilek Ural, İbrahim Oğuz Karaca, Can Ramazan Öncel, Cafer Zorkun and Sanem Nalbantgil.

    Who should attend

    Cardiologists, cardiology residents and fellows, and clinicians building expertise in heart failure and cardiomyopathy care.

    Registration and accreditation

    The organiser has not published fees or CME/CPD credits on its website, so none are shown here. Please contact the Turkish Society of Cardiology (tkd.org.tr) for registration; CME Gallery does not take bookings.

    Ratings & Reviews

    No ratings yet
    Dec 10 – Dec 13, 2026
    Istanbul · Turkish Society of Cardiology Centre, İstanbul, Türkiye
    Turkish
    FREE WEEKLY DIGEST

    Never miss a CME event

    Get curated events for your specialty — every week